nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—SLC6A2—locus ceruleus—bipolar disorder	0.0661	0.224	CbGeAlD
Dexmedetomidine—SLC6A2—autonomic nervous system—bipolar disorder	0.0351	0.119	CbGeAlD
Dexmedetomidine—CYP1A2—urine—bipolar disorder	0.022	0.0746	CbGeAlD
Dexmedetomidine—CYP2E1—urine—bipolar disorder	0.0198	0.0671	CbGeAlD
Dexmedetomidine—CYP2D6—urine—bipolar disorder	0.0157	0.0532	CbGeAlD
Dexmedetomidine—CYP1A2—blood plasma—bipolar disorder	0.0115	0.0389	CbGeAlD
Dexmedetomidine—ADRA2A—blood plasma—bipolar disorder	0.0106	0.0358	CbGeAlD
Dexmedetomidine—CYP2E1—blood plasma—bipolar disorder	0.0103	0.035	CbGeAlD
Dexmedetomidine—CYP2D6—blood plasma—bipolar disorder	0.00818	0.0277	CbGeAlD
Dexmedetomidine—ADRA1B—nervous system—bipolar disorder	0.00736	0.0249	CbGeAlD
Dexmedetomidine—ADRA1D—nervous system—bipolar disorder	0.00719	0.0244	CbGeAlD
Dexmedetomidine—ADRA2C—adrenal cortex—bipolar disorder	0.00672	0.0228	CbGeAlD
Dexmedetomidine—ADRA1B—brain—bipolar disorder	0.00562	0.0191	CbGeAlD
Dexmedetomidine—ADRA1D—brain—bipolar disorder	0.0055	0.0186	CbGeAlD
Dexmedetomidine—SLC6A2—nervous system—bipolar disorder	0.00445	0.0151	CbGeAlD
Dexmedetomidine—CYP1A2—thyroid gland—bipolar disorder	0.00406	0.0138	CbGeAlD
Dexmedetomidine—CYP1A1—thyroid gland—bipolar disorder	0.00401	0.0136	CbGeAlD
Dexmedetomidine—ADRA2C—nervous system—bipolar disorder	0.00394	0.0133	CbGeAlD
Dexmedetomidine—ADRA2A—thyroid gland—bipolar disorder	0.00374	0.0127	CbGeAlD
Dexmedetomidine—ADRA2C—cerebellum—bipolar disorder	0.00371	0.0126	CbGeAlD
Dexmedetomidine—CYP2E1—thyroid gland—bipolar disorder	0.00365	0.0124	CbGeAlD
Dexmedetomidine—SLC6A2—brain—bipolar disorder	0.0034	0.0115	CbGeAlD
Dexmedetomidine—CYP1A1—nervous system—bipolar disorder	0.00337	0.0114	CbGeAlD
Dexmedetomidine—ADRA2A—nervous system—bipolar disorder	0.00314	0.0107	CbGeAlD
Dexmedetomidine—CYP2E1—nervous system—bipolar disorder	0.00307	0.0104	CbGeAlD
Dexmedetomidine—ADRA2C—brain—bipolar disorder	0.00301	0.0102	CbGeAlD
Dexmedetomidine—ADRA2A—cerebellum—bipolar disorder	0.00296	0.01	CbGeAlD
Dexmedetomidine—CYP2E1—cerebellum—bipolar disorder	0.00289	0.0098	CbGeAlD
Dexmedetomidine—CYP1A1—brain—bipolar disorder	0.00258	0.00873	CbGeAlD
Dexmedetomidine—CYP2D6—nervous system—bipolar disorder	0.00243	0.00825	CbGeAlD
Dexmedetomidine—ADRA2A—brain—bipolar disorder	0.0024	0.00814	CbGeAlD
Dexmedetomidine—CYP2E1—brain—bipolar disorder	0.00235	0.00796	CbGeAlD
Dexmedetomidine—CYP2D6—cerebellum—bipolar disorder	0.00229	0.00776	CbGeAlD
Dexmedetomidine—CYP2D6—brain—bipolar disorder	0.00186	0.00631	CbGeAlD
Dexmedetomidine—ADRA2C—Signaling by GPCR—ADCY2—bipolar disorder	0.000195	0.000277	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—TSHB—bipolar disorder	0.000195	0.000277	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—TPH2—bipolar disorder	0.000195	0.000277	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CACNB2—bipolar disorder	0.000195	0.000277	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—SLC5A3—bipolar disorder	0.000195	0.000276	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TSHB—bipolar disorder	0.000193	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PDE4B—bipolar disorder	0.000193	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TACR1—bipolar disorder	0.000193	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—DRD2—bipolar disorder	0.000193	0.000274	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—ADCY2—bipolar disorder	0.000192	0.000273	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—DPYD—bipolar disorder	0.000192	0.000272	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	0.000191	0.000271	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—DRD2—bipolar disorder	0.00019	0.00027	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	0.000188	0.000267	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TRPC3—bipolar disorder	0.000188	0.000266	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	0.000186	0.000263	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	0.000186	0.000263	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	0.000184	0.000262	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	0.000183	0.000259	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NDUFV2—bipolar disorder	0.00018	0.000255	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	0.000179	0.000254	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	0.000179	0.000254	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ADM—bipolar disorder	0.000179	0.000254	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—IMPA1—bipolar disorder	0.000179	0.000254	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CACNA1C—bipolar disorder	0.000178	0.000253	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—HTR2A—bipolar disorder	0.000177	0.000251	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TRPC3—bipolar disorder	0.000175	0.000249	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000175	0.000248	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	0.000175	0.000248	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PDE4B—bipolar disorder	0.000175	0.000248	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TACR1—bipolar disorder	0.000175	0.000248	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TSHB—bipolar disorder	0.000175	0.000248	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AKR1C4—bipolar disorder	0.000174	0.000247	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PIK3C2A—bipolar disorder	0.000174	0.000247	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	0.000174	0.000246	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	0.000173	0.000245	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TRPC3—bipolar disorder	0.000173	0.000245	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	0.000171	0.000243	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	0.000169	0.000239	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ADM—bipolar disorder	0.000167	0.000237	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ADM—bipolar disorder	0.000165	0.000234	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TSHB—bipolar disorder	0.000163	0.000231	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TACR1—bipolar disorder	0.000163	0.000231	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PDE4B—bipolar disorder	0.000163	0.000231	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CLOCK—bipolar disorder	0.000163	0.000231	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—HTR2A—bipolar disorder	0.000161	0.000228	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PDE4B—bipolar disorder	0.000161	0.000228	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TACR1—bipolar disorder	0.000161	0.000228	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TSHB—bipolar disorder	0.000161	0.000228	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR1A—bipolar disorder	0.00016	0.000227	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—HTR2A—bipolar disorder	0.00016	0.000226	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	0.000159	0.000225	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—TSHB—bipolar disorder	0.000158	0.000225	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—TPH2—bipolar disorder	0.000158	0.000225	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CACNB2—bipolar disorder	0.000158	0.000225	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TAC1—bipolar disorder	0.000158	0.000224	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	0.000157	0.000223	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NR1D1—bipolar disorder	0.000156	0.000222	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—SNAP25—bipolar disorder	0.000156	0.000221	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—DPYD—bipolar disorder	0.000156	0.000221	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2C—bipolar disorder	0.000155	0.000219	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—DRD1—bipolar disorder	0.000155	0.000219	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NDUFV2—bipolar disorder	0.000152	0.000216	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NTRK2—bipolar disorder	0.00015	0.000213	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—DRD3—bipolar disorder	0.00015	0.000212	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—NCAN—bipolar disorder	0.00015	0.000212	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CLOCK—bipolar disorder	0.000149	0.000212	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—HTR2A—bipolar disorder	0.000149	0.000212	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—GSK3A—bipolar disorder	0.000149	0.000212	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AKR1C4—bipolar disorder	0.000148	0.000209	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—HTR2A—bipolar disorder	0.000147	0.000208	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	0.000147	0.000208	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—TPH2—bipolar disorder	0.000146	0.000206	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—TSHB—bipolar disorder	0.000146	0.000206	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CACNB2—bipolar disorder	0.000146	0.000206	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—DRD4—bipolar disorder	0.000145	0.000206	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—HTR2A—bipolar disorder	0.000145	0.000206	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CACNA1C—bipolar disorder	0.000145	0.000206	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR1A—bipolar disorder	0.000145	0.000205	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—DPYD—bipolar disorder	0.000143	0.000203	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	0.000143	0.000202	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TAC1—bipolar disorder	0.000142	0.000202	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	0.000141	0.0002	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—POMC—bipolar disorder	0.000141	0.0002	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CLOCK—bipolar disorder	0.000141	0.0002	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—DRD1—bipolar disorder	0.00014	0.000198	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2C—bipolar disorder	0.00014	0.000198	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ADCY2—bipolar disorder	0.000138	0.000196	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—TPH2—bipolar disorder	0.000137	0.000195	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—TSHB—bipolar disorder	0.000137	0.000195	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CACNB2—bipolar disorder	0.000137	0.000195	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ADCY2—bipolar disorder	0.000137	0.000194	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TCF7L2—bipolar disorder	0.000136	0.000193	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADM—bipolar disorder	0.000136	0.000193	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NTRK2—bipolar disorder	0.000136	0.000193	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—DRD2—bipolar disorder	0.000135	0.000192	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—HTR2A—bipolar disorder	0.000135	0.000192	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—DRD3—bipolar disorder	0.000135	0.000192	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR1A—bipolar disorder	0.000135	0.000192	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—DPYD—bipolar disorder	0.000135	0.000191	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—GSK3A—bipolar disorder	0.000135	0.000191	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—HTR2A—bipolar disorder	0.000133	0.000189	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CACNA1C—bipolar disorder	0.000133	0.000189	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TAC1—bipolar disorder	0.000133	0.000189	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR1A—bipolar disorder	0.000133	0.000189	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	0.000133	0.000188	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	0.000133	0.000188	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	0.000133	0.000188	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NR1D1—bipolar disorder	0.000132	0.000188	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—DRD4—bipolar disorder	0.000131	0.000186	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TAC1—bipolar disorder	0.000131	0.000186	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2C—bipolar disorder	0.00013	0.000185	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—DRD1—bipolar disorder	0.00013	0.000185	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PIK3C2A—bipolar disorder	0.00013	0.000184	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—DRD1—bipolar disorder	0.000128	0.000182	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2C—bipolar disorder	0.000128	0.000182	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—POMC—bipolar disorder	0.000128	0.000182	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—POMC—bipolar disorder	0.000128	0.000181	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NTRK2—bipolar disorder	0.000127	0.00018	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—NCAN—bipolar disorder	0.000127	0.00018	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—SNAP25—bipolar disorder	0.000127	0.00018	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—DRD3—bipolar disorder	0.000126	0.000179	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—GSK3A—bipolar disorder	0.000126	0.000178	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CACNA1C—bipolar disorder	0.000125	0.000178	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NTRK2—bipolar disorder	0.000125	0.000177	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—DRD3—bipolar disorder	0.000124	0.000176	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SLC5A3—bipolar disorder	0.000124	0.000176	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—GSK3A—bipolar disorder	0.000124	0.000176	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ADCY2—bipolar disorder	0.000124	0.000175	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TCF7L2—bipolar disorder	0.000123	0.000175	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NTRK1—bipolar disorder	0.000123	0.000174	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—DRD4—bipolar disorder	0.000123	0.000174	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—DRD2—bipolar disorder	0.000122	0.000173	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	0.000122	0.000173	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	0.000121	0.000172	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—DRD4—bipolar disorder	0.000121	0.000171	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000121	0.000171	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—S100B—bipolar disorder	0.000119	0.000169	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—POMC—bipolar disorder	0.000119	0.000169	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—COMT—bipolar disorder	0.000118	0.000168	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—MAOA—bipolar disorder	0.000117	0.000166	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—POMC—bipolar disorder	0.000117	0.000166	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—SNAP25—bipolar disorder	0.000116	0.000165	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—POMC—bipolar disorder	0.000116	0.000164	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ADCY2—bipolar disorder	0.000115	0.000164	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TCF7L2—bipolar disorder	0.000115	0.000163	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—DRD2—bipolar disorder	0.000114	0.000162	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	0.000114	0.000161	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	0.000113	0.000161	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	0.000112	0.000159	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ADCY2—bipolar disorder	0.000112	0.000159	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NTRK1—bipolar disorder	0.000111	0.000157	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	0.00011	0.000156	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	0.00011	0.000156	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—SNAP25—bipolar disorder	0.00011	0.000156	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—POMC—bipolar disorder	0.000108	0.000153	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	0.000108	0.000153	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—S100B—bipolar disorder	0.000108	0.000153	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	0.000106	0.000151	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CLOCK—bipolar disorder	0.000106	0.00015	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	0.000106	0.00015	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	0.000106	0.00015	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	0.000105	0.000149	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NTRK1—bipolar disorder	0.000103	0.000147	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—TSHB—bipolar disorder	0.000103	0.000146	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—TPH2—bipolar disorder	0.000103	0.000146	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CACNB2—bipolar disorder	0.000103	0.000146	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	0.000103	0.000146	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ADCY2—bipolar disorder	0.000103	0.000146	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	0.000103	0.000146	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	0.000102	0.000145	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	0.000102	0.000144	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—DPYD—bipolar disorder	0.000102	0.000144	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—S100B—bipolar disorder	0.000101	0.000143	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	9.96e-05	0.000141	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—S100B—bipolar disorder	9.89e-05	0.00014	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ADCY2—bipolar disorder	9.71e-05	0.000138	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	9.67e-05	0.000137	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—COMT—bipolar disorder	9.6e-05	0.000136	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—MTHFR—bipolar disorder	9.55e-05	0.000136	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—MAOA—bipolar disorder	9.53e-05	0.000135	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NRG1—bipolar disorder	9.5e-05	0.000135	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	9.49e-05	0.000135	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	9.44e-05	0.000134	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	9.37e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	9.34e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	9.28e-05	0.000132	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	9.2e-05	0.000131	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CLOCK—bipolar disorder	8.98e-05	0.000127	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NRG1—bipolar disorder	8.87e-05	0.000126	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—COMT—bipolar disorder	8.82e-05	0.000125	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	8.78e-05	0.000125	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MAOA—bipolar disorder	8.75e-05	0.000124	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—TSHB—bipolar disorder	8.75e-05	0.000124	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CACNB2—bipolar disorder	8.75e-05	0.000124	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—TPH2—bipolar disorder	8.75e-05	0.000124	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	8.73e-05	0.000124	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—DPYD—bipolar disorder	8.61e-05	0.000122	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2A—bipolar disorder	8.56e-05	0.000121	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	8.4e-05	0.000119	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—COMT—bipolar disorder	8.31e-05	0.000118	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—SNAP25—bipolar disorder	8.25e-05	0.000117	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MAOA—bipolar disorder	8.25e-05	0.000117	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—S100B—bipolar disorder	8.17e-05	0.000116	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	8e-05	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2A—bipolar disorder	8e-05	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	7.87e-05	0.000112	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	7.8e-05	0.000111	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—MTHFR—bipolar disorder	7.76e-05	0.00011	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.69e-05	0.000109	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—POMC—bipolar disorder	7.64e-05	0.000108	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	7.64e-05	0.000108	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—INS—bipolar disorder	7.6e-05	0.000108	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—POMC—bipolar disorder	7.58e-05	0.000107	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—INS—bipolar disorder	7.53e-05	0.000107	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ADCY2—bipolar disorder	7.31e-05	0.000104	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	7.21e-05	0.000102	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTHFR—bipolar disorder	7.13e-05	0.000101	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SNAP25—bipolar disorder	6.99e-05	9.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—GSK3B—bipolar disorder	6.9e-05	9.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—POMC—bipolar disorder	6.84e-05	9.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—INS—bipolar disorder	6.8e-05	9.65e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTHFR—bipolar disorder	6.72e-05	9.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	6.5e-05	9.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—GSK3B—bipolar disorder	6.44e-05	9.14e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—POMC—bipolar disorder	6.39e-05	9.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—INS—bipolar disorder	6.35e-05	9.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	6.34e-05	8.99e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—POMC—bipolar disorder	6.29e-05	8.92e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—COMT—bipolar disorder	6.26e-05	8.87e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—INS—bipolar disorder	6.25e-05	8.87e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MAOA—bipolar disorder	6.21e-05	8.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—POMC—bipolar disorder	6.21e-05	8.8e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ADCY2—bipolar disorder	6.19e-05	8.78e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—INS—bipolar disorder	6.17e-05	8.75e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—POMC—bipolar disorder	5.7e-05	8.08e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—INS—bipolar disorder	5.67e-05	8.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—POMC—bipolar disorder	5.37e-05	7.62e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—INS—bipolar disorder	5.34e-05	7.58e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—COMT—bipolar disorder	5.3e-05	7.52e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MAOA—bipolar disorder	5.26e-05	7.46e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	5.23e-05	7.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—POMC—bipolar disorder	5.19e-05	7.36e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—INS—bipolar disorder	5.16e-05	7.32e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—bipolar disorder	5.06e-05	7.17e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—bipolar disorder	4.28e-05	6.08e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—POMC—bipolar disorder	4.04e-05	5.74e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—INS—bipolar disorder	4.02e-05	5.7e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—POMC—bipolar disorder	3.43e-05	4.86e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—INS—bipolar disorder	3.41e-05	4.83e-05	CbGpPWpGaD
